Načítá se...
A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
Tumor‐induced osteomalacia (TIO) is a rare cause of impaired bone mineralization mediated by the osteocyte‐derived, phosphaturic hormone: fibroblast growth factor 23 (FGF23). The case is presented of a previously healthy 45‐year‐old man who developed fragility fractures at multiple sites (initially...
Uloženo v:
| Vydáno v: | JBMR Plus |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872335/ https://ncbi.nlm.nih.gov/pubmed/33615107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10438 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|